Cremezin hits in the market in 5 moths from its launching.

CJ pharmaceutical division recently launched Cremezin, a drug for delaying a kidney dialysis, and achieved a tremendous success just within 5 months from its market entry in Feb. this year to an extent that about 80 major hospitals with over 300 beds including Severance and Korea Univ. hospital massively prescribed it, which is extremely exceptional in Korea

Main reasons for such unprecedent...